Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia 21-09-2024, 15:15

Matterport Revolutionizes Enterprise Facility Monitoring with AWS IoT TwinMaker and Immersive Real-Time Digital Twins 17-04-2023, 14:00

Moringa Magic Reviews (2025 WARNING): What Buyers Discovered About Its Energy, Immunity & Weight Loss Benefits Will Shock You 8-04-2025, 01:24